Pathogenesis of selective expansion of PNH clones

International Journal of Hematology

Volumn 77, Issue 2, 2003, Pages 121-124

  Nakakuma, Hideki ^a   Kawaguchi, Tatsuya ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Clonal expansion; Glycosylphosphatidylinositol; Natural killer cells; Paroxysmal nocturnal hemoglobinuria; PIG A

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL GLYCAN CLASS A PROTEIN; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN;

APLASTIC ANEMIA; ARTICLE; CLINICAL FEATURE; CLONE; CYTOTOXIC T LYMPHOCYTE; GENE; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMOGLOBINURIA; HUMAN; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PIG A GENE; SURVIVAL RATE; CELL CLONE; CELL DIVISION; CYTOTOXICITY; GENETICS; IMMUNOLOGY; PATHOLOGY; REVIEW;

CELL DIVISION; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MEMBRANE PROTEINS;

EID: 0038651144     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983210     Document Type: Article

References (43)

1. Parker CJ, Lee GR. Paroxysmal nocturnal hemoglobinuria. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, eds. Wintrobe's Clinical Hematology. Vol 1. 10th ed. Baltimore, Md: Williams & Wilkins; 1999:1264-1288.
2. Hillman P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333:1253-1258.
3. Socie G, Mary JY, De Gramont A, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. Lancet. 1996;348:573-577.
4. Rosse WF. Evolution of clinical understanding: paroxysmal nocturnal hemoglobinuria as a paradigm. Am J Hematol. 1993;42:122-126.
5. Nakakuma H. Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH). Am J Hematol. 1996;53:22-29.
6. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703-711.
7. Tremml G, Dominguez C, Rosti V, et al. Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Pig a gene. Blood. 1999;94:2945-2954.
8. Murakami Y, Kinoshita T, Maeda Y, Nakano T, Kosaka H, Takeda J. Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria. Blood. 1999;94:2963-2970.
9. Dunn DE, Ware RE, Parker CJ, et al. Research directions in paroxysmal nocturnal hemoglobinuria. Immunol Today. 1999;20:168-171.
10. van der Schoot CE, Huizinga TW, van't Veerkorthof ET, Wijmans R, Pinkster J, von dem Borne AE. Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria. Blood. 1990;76:1853-1859.
11. Schrezenmeier H, Hertenstein B, Wagner B, Raghavachar A, Heimpel H. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Exp Hematol. 1995;23:81-87.
12. Azenishi Y, Ueda E, Machii T, et al. CD59-deficient blood cells and PIG-A gene abnormalities in Japanese patients with aplastic anaemia. Br J Haematol. 1999;104:523-529.
13. Dunn DE, Liu JM, Young NS. Paroxysmal nocturnal hemoglobinuria. In: Young NS, ed. Bone Marrow Failure Syndromes. Philadelphia, Pa: WB Saunders; 2000:99-121.
14. Nakakuma H, Nagakura S, Iwamoto N, et al. Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia. Blood. 1995;85:1371-1376.
15. Iwamoto N, Kawaguchi T, Horikawa K, et al. Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafeted in SCID mice. Blood. 1996;87:4944-4948.
16. Araten DJ, Bessler M, McKenzie S, et al. Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia. 2002;16:2243-2248.
17. Maciejewski JP, Sloand EM, Sato T, et al. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone. Blood. 1997;89:1173-1181.
18. Nakao S, Takamatsu H, Chuhjo T, et al. Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood. 1994;84:4257-4261.
19. Young NS. Acquired aplastic anemia. In: Young NS, ed. Bone Marrow Failure Syndromes. Philadelphia, Pa: WB Saunders; 2000:1-46.
20. Horikawa K, Fujisao S, Iwamoto N, et al. Cyclosporin-responsive pancytopenia and HLA class II alleles of a patients with paroxysmal nocturnal hemoglobinuria. Int J Hematol. 1996;63:165-166.
21. Horikawa K, Nakakuma H, Kawaguchi T, et al. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood. 1997;90:2716-2722.
22. Brodsky RA, Vala MS, Barber JP, et al. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A. 1997;94:8756-8760.
23. Ware RE, Nishimura J, Moody MA, et al. The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria. Blood. 1998;92:2541-2550.
24. Raza A, Gezer S, Mundle S, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995;86:268-276.
25. Dunbar CE, Saunthararajah Y. Myelodysplastic syndromes. In: Young NS, ed. Bone Marrow Failure Syndromes. Philadelphia, Pa: WB Saunders; 2000:69-98.
26. Iwanaga M, Furukawa K, Amenomori T, et al. Paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes. Br J Haematol. 1998;102:465-474.
27. -, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma. Blood. 1995;86:1487-1492.
28. Dunn DE, Tanawattanacharoen P, Boccuni P, et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med. 1999;131:401-408.
29. Karadimitris A, Notaro R, Koehne G, Roberts IA, Luzzatto L. PNH cells are as sensitive to T-cell-mediated lysis as their normal counterparts: implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2000;111:1158-1163.
30. Nagakura S, Ishihara S, Dunn DE, et al. Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro. Blood. 2002;100:1031-1037.
31. Murakami Y, Kosaka H, Maeda Y, et al. Insufficient response of T lymphocytes to GPI-anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria. Blood. 2002;100:4116-4122.
32. Nakakuma H, Nagakura S, Kawaguchi T, et al. Markedly high plasma erythropoietin and granulocyte-colony stimulating factor levels in patients with paroxysmal nocturnal hemoglobinuria. Int J Hematol. 1997;66:451-457.
33. Ljunggren HG, Karre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today. 1990;11:237-244.
34. Cosman D, Mulliberg J, Sutherland CL, et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 2001;14:123-133.
35. Lanier LL. A renaissance for the tumor immunosurveilance hypothesis. Nat Med. 2001;7:1178-1180.
36. Long EO, Rajagopalan S. Stress signals activate natural killer cells. J Exp Med. 2002;196:1399-1402.
37. Harris JW, Koscick T, Lazarus HM, Eshleman JR, Medof ME. Leukemia arising out of paroxysmal nocturnal hemoglobinuria. Leuk Lymphoma. 1999;32:301-426.
38. Hattori H, Machii T, Ueda E, Shibano M, Kageyama T, Kitani T. Increased frequency of somatic mutations at glycophorin A loci in patients with aplastic anaemia, myelodysplastic syndrome and paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1997;98:384-391.
39. Ishihara S, Nakakuma H, Kawaguchi T, et al. Two cases showing clonal progession with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia. Int J Hematol. 2000;72:206-209.
40. Araten DJ, Swirski D, Karadimitris A, et al. Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2001;115:360-368.
41. Horikawa K, Kawaguchi T, Ishihara S, et al. Frequent detection of T cells with mutations of the hypoxanthine-guanine phosphoribosyl transferase gene in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2002;99:24-29.
42. Lyakisheva A, Felda O, Ganser A, et al. Paroxysmal nocturnal hemoglobinuria: Differential gene expression of EGR-1 and TAXREB107. Exp Hematol. 2002;30:18-25.
43. Shichishima T, Okamoto M, Ikeda K, et al. HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobnuria. Blood. 2002;100:22-28.